New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities.

Authors:
Dai M; Liu M; Yang H; Küçük C; You H.

Journal:
Exp Hematol Oncol

Publication Year: 2022

DOI:
10.1186/s40164-022-00356-0

PMCID:
PMC9667634

PMID:
36384676

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabil…
Zhou W; Li S; Wang H and 8 more (2024) - Transparency Score: 4/6
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive …
Shen XT; Xie SZ; Zheng X and 17 more (2024) - Transparency Score: 4/6
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting c…
Zhao Q; Zong H; Zhu P and 4 more (2024) - Transparency Score: 3/6
Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, …
Liu J; Jiang P; Lu Z and 2 more (2024) - Transparency Score: 3/6
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.
Zhou L; Lu Y; Liu W and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding The work in the lab was supported by the National Natural Science Foundation of China (81911530169) and the University Special Innovative Research Program of the Department of Education of Guangdong Province (2020KQNCX073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025